company background image
2877 logo

China Shineway Pharmaceutical Group Informe acción SEHK:2877

Último precio

HK$8.13

Capitalización de mercado

HK$6.1b

7D

-3.3%

1Y

15.2%

Actualizada

23 Nov, 2024

Datos

Finanzas de la empresa +

China Shineway Pharmaceutical Group Limited

Informe acción SEHK:2877

Capitalización de mercado: HK$6.1b

Resumen de acción 2877

China Shineway Pharmaceutical Group Limited, un holding de inversiones, se dedica a la investigación y el desarrollo, la fabricación y el comercio de medicamentos chinos en la República Popular China y Hong Kong. Saber más

Análisis fundamental de 2877
Puntuación del snowflake
Valoración5/6
Crecimiento futuro2/6
Rendimiento pasado5/6
Salud financiera5/6
Dividendos4/6

Competidores de China Shineway Pharmaceutical Group Limited

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de China Shineway Pharmaceutical Group
Precios históricos de las acciones
Precio actual de la acciónHK$8.13
Máximo en las últimas 52 semanasHK$10.72
Mínimo de 52 semanasHK$6.61
Beta0.81
1Cambio en 1 mes-13.88%
Variación en 3 meses0.74%
Cambio de 1 año15.16%
3Variación en 3 años14.83%
Variación en 5 años1.25%
Variación desde la OPV68.50%

Noticias y actualizaciones recientes

China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Oct 18
China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Recent updates

China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Oct 18
China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Right But Growth Is Lacking After Shares Rocket 27%

If EPS Growth Is Important To You, China Shineway Pharmaceutical Group (HKG:2877) Presents An Opportunity

Jun 03
If EPS Growth Is Important To You, China Shineway Pharmaceutical Group (HKG:2877) Presents An Opportunity

Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?

May 13
Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?

China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461

Apr 26
China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461

Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 41%?

Apr 17
Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 41%?

China Shineway Pharmaceutical Group (HKG:2877) Is Increasing Its Dividend To CN¥0.461

Mar 31
China Shineway Pharmaceutical Group (HKG:2877) Is Increasing Its Dividend To CN¥0.461

China Shineway Pharmaceutical Group Limited's (HKG:2877) 26% Price Boost Is Out Of Tune With Earnings

Mar 14
China Shineway Pharmaceutical Group Limited's (HKG:2877) 26% Price Boost Is Out Of Tune With Earnings

Does China Shineway Pharmaceutical Group (HKG:2877) Deserve A Spot On Your Watchlist?

Jan 29
Does China Shineway Pharmaceutical Group (HKG:2877) Deserve A Spot On Your Watchlist?

China Shineway Pharmaceutical Group (HKG:2877) Seems To Use Debt Rather Sparingly

Sep 28
China Shineway Pharmaceutical Group (HKG:2877) Seems To Use Debt Rather Sparingly

China Shineway Pharmaceutical Group (HKG:2877) Is Paying Out A Dividend Of CN¥0.118

Sep 01
China Shineway Pharmaceutical Group (HKG:2877) Is Paying Out A Dividend Of CN¥0.118

We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease

Aug 03
We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease

Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 44%?

May 30
Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 44%?

We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease

Mar 07
We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease

China Shineway Pharmaceutical Group's (HKG:2877) Dividend Will Be Reduced To CN¥0.125

Sep 01
China Shineway Pharmaceutical Group's (HKG:2877) Dividend Will Be Reduced To CN¥0.125

China Shineway Pharmaceutical Group Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 31
China Shineway Pharmaceutical Group Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet

Apr 07
China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet

China Shineway Pharmaceutical Group's(HKG:2877) Share Price Is Down 55% Over The Past Three Years.

Mar 11
China Shineway Pharmaceutical Group's(HKG:2877) Share Price Is Down 55% Over The Past Three Years.

Should You Buy China Shineway Pharmaceutical Group Limited (HKG:2877) For Its Dividend?

Feb 18
Should You Buy China Shineway Pharmaceutical Group Limited (HKG:2877) For Its Dividend?

Should You Use China Shineway Pharmaceutical Group's (HKG:2877) Statutory Earnings To Analyse It?

Jan 31
Should You Use China Shineway Pharmaceutical Group's (HKG:2877) Statutory Earnings To Analyse It?

Is China Shineway Pharmaceutical Group Limited (HKG:2877) Trading At A 49% Discount?

Jan 13
Is China Shineway Pharmaceutical Group Limited (HKG:2877) Trading At A 49% Discount?

What Is The Ownership Structure Like For China Shineway Pharmaceutical Group Limited (HKG:2877)?

Dec 25
What Is The Ownership Structure Like For China Shineway Pharmaceutical Group Limited (HKG:2877)?

We Think China Shineway Pharmaceutical Group (HKG:2877) Can Manage Its Debt With Ease

Dec 10
We Think China Shineway Pharmaceutical Group (HKG:2877) Can Manage Its Debt With Ease

Reflecting on China Shineway Pharmaceutical Group's (HKG:2877) Share Price Returns Over The Last Five Years

Nov 25
Reflecting on China Shineway Pharmaceutical Group's (HKG:2877) Share Price Returns Over The Last Five Years

Rentabilidad de los accionistas

2877HK PharmaceuticalsMercado HK
7D-3.3%0.07%-0.6%
1Y15.2%-10.2%9.6%

Rentabilidad vs. Industria: 2877 superó a la industria Hong Kong Pharmaceuticals, que obtuvo un rendimiento del -10.2% el año pasado.

Rentabilidad vs. Mercado: 2877 superó al mercado Hong Kong, que obtuvo un rendimiento del 9.6% el año pasado.

Volatilidad de los precios

Is 2877's price volatile compared to industry and market?
2877 volatility
2877 Average Weekly Movement5.2%
Pharmaceuticals Industry Average Movement6.8%
Market Average Movement8.9%
10% most volatile stocks in HK Market19.2%
10% least volatile stocks in HK Market4.3%

Precio estable de las acciones: 2877 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de 2877 (5%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
20023,232n/awww.shineway.com

China Shineway Pharmaceutical Group Limited, un holding de inversiones, se dedica a la investigación y el desarrollo, la fabricación y el comercio de medicamentos chinos en la República Popular China y Hong Kong. La empresa ofrece medicamentos chinos en forma de inyección, cápsulas blandas y gránulos; comprimidos, píldoras, líquido oral y polvo; y gránulos de medicina tradicional china en diversas áreas terapéuticas, como enfermedades del sistema respiratorio, del sistema nervioso, del sistema digestivo, cardiovasculares y cerebrovasculares, ortopedia, pediatría y otras áreas, así como medicamentos para fortalecer el organismo. También se dedica al comercio de productos agrícolas y a la investigación y desarrollo de productos farmacéuticos chinos.

Resumen de fundamentos de China Shineway Pharmaceutical Group Limited

¿Cómo se comparan los beneficios e ingresos de China Shineway Pharmaceutical Group con su capitalización de mercado?
Estadísticas fundamentales de 2877
Capitalización bursátilHK$6.14b
Beneficios(TTM)HK$1.19b
Ingresos (TTM)HK$4.52b

5.2x

Ratio precio-beneficio (PE)

1.4x

Ratio precio-ventas (PS)

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de 2877
IngresosCN¥4.20b
Coste de los ingresosCN¥1.04b
Beneficio brutoCN¥3.16b
Otros gastosCN¥2.06b
BeneficiosCN¥1.10b

Últimos beneficios comunicados

Jun 30, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)1.46
Margen bruto75.21%
Margen de beneficio neto26.27%
Ratio deuda/patrimonio4.5%

¿Cómo se ha desempeñado 2877 a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

6.9%

Rentabilidad actual por dividendo

37%

Ratio de pagos